ENG OUR PASSION, YOUR HEALTH. INNOVATION, QUALITY, INTERNATIONALIZATION, COMPETITIVENESS. These are the guiding principles of Fidia - your specialist in hyaluronic acid! Principles to which we commit ourselves with our employees and in our ideas in order to develop solutions with added value for patients and therapists. We face this challenge. Fidia Pharma GmbH has been on the German market since the beginning of 2014 and uses the strength of its parent company Fidia Farmaceutici SpA, which has gained significant experience in the research, development and marketing of therapy options with hyaluronic acid over more than 50 years. We currently offer innovative treatment options for osteoarthritis therapy and modern wound management. From the specialist - for the specialist! HERE YOU CAN FIND OUT MORE ABOUT IT „Hymovis“, „Hyalart“, „Hyalubrix“, „HyalOne“ sowie „3D MO.RE Technology“ sind eingetragene Marken der Fidia Farmaceutici S.p.A. und ggf. nicht gesondert gekennzeichnet. Aus dem Fehlen der Kennzeichnung kann nicht geschlossen werden, dass es sich bei einem Produkt, einem Begriff oder einem Bild nicht um eine eingetragene Marke handelt. FIDIA WELTWEIT Entdecken Sie auch die internationalen Webseiten von Fidia: FIDIA FARMACEUTICI S.P.A. FIDIA PHARMA USA INC FIDIA FARMACEUTICA S.L.U. Fidia Pharma GmbH Fidia is the global leader in hyaluronic acid (HA). 50 years of experience in research and development are the strong basis for unique, innovative and high quality hyaluronic acids in osteoarthritis therapy, in wound care and in ophthalmology / medical eye care. In the field of regenerative medicine, Fidia Pharma GmbH focuses on highly concentrated thrombocytes (platelet rich plasma - PRP). Fidia Pharma GmbH, Opladener Straße 149 - 40789 Monheim E-Mail: service@fidiapharma.de © 2014-2016 Fidia Farmaceutici spa, Abano Terme, Italy Engineered by Gruppo 4 srl DATA PROTECTIONCONDITIONSIMPRINTRETURNS POLICY